Indian Company Master Data Made Simple
Sun Pharmaceutical Industries Limited
Since 1993, Sun Pharmaceutical Industries Limited has maintained a presence in the industry for 33 years. It is registered under CIN L24230GJ1993PLC019050 and registration number 19050. It falls under the category of company limited by shares. Its authorized capital has been set at ₹617.97 crore. Its paid up capital is ₹239.93 crore.
Mainly engaged in manufacture of chemicals and chemical products. It operates under Ahmedabad’s corporate registry. The official address of incorporation is Sparc, Tandalja, Vadodara, Vadodara, Gujarat, India, 390012. Its current corporate status is active. The firm is identified under PAN AADCS3124K. The Legal Entity Identifier assigned to the company is 335800KJ7GE29LB4SS73. For inquiries or official matters, please email anoop.deshpande@sunpharma.com. Sun Pharmaceutical Industries Limited’s leadership roster features Jayashree Satagopan (CFO) and Jayashree Satagopan (CFO).
Company Overview
- CIN
- Date of Incorporation
- 28/02/1993
- Company Status
- Active
- RoC
- Ahmedabad
- Registration Number
- Balance sheet date
- 31/03/2025
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹6,17,97,00,000.00
- Paid up Capital
- ₹2,39,93,34,970.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- anoop.deshpande@sunpharma.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Assam | 18AADCS3124K2ZB | Inactive |
| 18AADCS3124K1ZC | Active | |
| Andhra Pradesh | 37AADCS3124K1ZC | Active |
| Bihar | 10AADCS3124K1ZS | Active |
| Chandigarh | 04AADCS3124K2ZK | Inactive |
| 04AADCS3124K1ZL | Inactive | |
| Chhattisgarh | 22AADCS3124K1ZN | Active |
| Delhi | 07AADCS3124K1ZF | Active |
| Dadra and Nagar Haveli and Daman and Diu | 26AADCS3124K1ZF | Active |
| Daman and Diu | 25AADCS3124K1ZH | Inactive |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| IN8044A01019 | SUN PHARMACEUTICAL INDUSTRIES LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | SUN PHARMA IND/SH VTG | ESVUFN |
| INE044A04014 | SUN PHARMACEUTICAL INDUSTRIES LTD. 6% PREF 091005 | - | 12/10/2026 | SUN PHARMA IND/6 CU PREF | EPVRFN |
| INE044A01036 | SUN PHARMACEUTICAL INDUSTRIES LIMITED EQ NEW F.V. RE.1/- | - | 12/10/2026 | SUN PHARMA IND/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹12,63,732.00L | ₹11,48,675.00L | ₹11,48,883.00L | ₹11,48,412.00L | ₹0.00L |
| Goodwill | ₹9,83,308.00L | ₹8,93,942.00L | ₹8,56,899.00L | ₹8,35,803.00L | ₹0.00L |
| Gross PPE | ₹28,15,259.00L | ₹25,06,153.00L | ₹24,06,487.00L | ₹23,10,675.00L | ₹0.00L |
| Inventory | ₹11,49,293.00L | ₹10,24,333.00L | ₹9,86,829.00L | ₹10,51,305.00L | ₹0.00L |
| Total Debt | ₹4,62,732.00L | ₹2,36,219.00L | ₹3,27,367.00L | ₹6,88,587.00L | ₹0.00L |
| Common Stock | ₹23,993.00L | ₹23,993.00L | ₹23,993.00L | ₹23,993.00L | ₹0.00L |
| Current Debt | ₹4,05,035.00L | ₹1,86,711.00L | ₹2,84,436.00L | ₹6,19,788.00L | ₹0.00L |
| Share Issued | ₹23,993.35L | ₹23,993.35L | ₹23,993.35L | ₹23,993.35L | ₹0.00L |
| Total Assets | ₹1,08,78,522.00L | ₹92,10,058.00L | ₹85,49,965.00L | ₹80,74,359.00L | ₹0.00L |
| Capital Stock | ₹23,993.00L | ₹23,993.00L | ₹23,993.00L | ₹23,993.00L | ₹0.00L |
| Long Term Debt | ₹3,126.00L | ₹252.00L | ₹133.00L | ₹0.00L | ₹0.00L |
| Current Assets | ₹63,89,119.00L | ₹52,62,447.00L | ₹43,47,498.00L | ₹39,88,334.00L | ₹0.00L |
| Prepaid Assets | ₹3,01,022.00L | ₹2,84,911.00L | ₹2,79,189.00L | ₹2,33,374.00L | ₹0.00L |
| Working Capital | ₹41,26,915.00L | ₹34,43,026.00L | ₹26,49,058.00L | ₹19,97,634.00L | ₹0.00L |
| Invested Capital | ₹87,65,170.00L | ₹74,08,765.00L | ₹66,51,244.00L | ₹62,19,326.00L | ₹0.00L |
| Other Properties | ₹11,11,411.00L | ₹10,03,594.00L | ₹10,19,232.00L | ₹10,39,038.00L | ₹0.00L |
| Retained Earnings | ₹69,35,463.00L | ₹57,86,184.00L | ₹50,15,455.00L | ₹43,61,025.00L | ₹0.00L |
| Common Stock Equity | ₹83,57,009.00L | ₹72,21,802.00L | ₹63,66,675.00L | ₹55,99,538.00L | ₹0.00L |
| Net Tangible Assets | ₹60,19,085.00L | ₹54,25,806.00L | ₹46,36,477.00L | ₹38,31,051.00L | ₹0.00L |
| Tangible Book Value | ₹60,19,085.00L | ₹54,25,806.00L | ₹46,36,477.00L | ₹38,31,051.00L | ₹0.00L |
| Current Liabilities | ₹22,62,204.00L | ₹18,19,421.00L | ₹16,98,440.00L | ₹19,90,700.00L | ₹0.00L |
| Long Term Provisions | ₹947.00L | ₹1,158.00L | ₹1,417.00L | ₹1,672.00L | ₹0.00L |
| Stockholders Equity | ₹83,57,009.00L | ₹72,21,802.00L | ₹63,66,675.00L | ₹55,99,538.00L | ₹0.00L |
| Other Equity Interest | ₹83,33,016.00L | ₹71,97,809.00L | ₹63,42,682.00L | ₹55,75,545.00L | ₹0.00L |
| Total Capitalization | ₹83,60,135.00L | ₹72,22,054.00L | ₹63,66,808.00L | ₹55,99,538.00L | ₹0.00L |
| Hedging Assets Current | ₹1,769.00L | ₹6,525.00L | ₹3,495.00L | ₹2,023.00L | ₹0.00L |
| Ordinary Shares Number | ₹23,993.35L | ₹23,993.35L | ₹23,993.35L | ₹23,993.35L | ₹0.00L |
| Other Intangible Assets | ₹13,54,616.00L | ₹9,02,054.00L | ₹8,73,299.00L | ₹9,32,684.00L | ₹0.00L |
| Other Non Current Assets | ₹47,100.00L | ₹54,012.00L | ₹47,393.00L | ₹5,15,769.70L | ₹0.00L |
| Total Non Current Assets | ₹44,89,403.00L | ₹39,47,611.00L | ₹42,02,467.00L | ₹40,86,025.00L | ₹0.00L |
| Cash And Cash Equivalents | ₹9,77,051.00L | ₹10,26,877.00L | ₹9,28,565.00L | ₹4,62,373.00L | ₹0.00L |
| Construction In Progress | ₹1,52,321.00L | ₹1,45,081.00L | ₹1,29,651.00L | ₹1,09,374.00L | ₹0.00L |
| Accumulated Depreciation | -₹15,51,527.00L | -₹13,57,478.00L | -₹12,57,604.00L | -₹11,62,263.00L | ₹0.00L |
| Additional Paid In Capital | ₹1,18,816.00L | ₹1,18,816.00L | ₹1,18,816.00L | ₹1,18,816.00L | ₹0.00L |
| Other Short Term Investments | ₹24,01,095.00L | ₹16,04,887.00L | ₹10,04,300.00L | ₹10,79,113.00L | ₹0.00L |
| Other Non Current Liabilities | ₹63,942.00L | ₹1,918.00L | ₹1,120.00L | ₹1,295.00L | ₹0.00L |
| Machinery Furniture Equipment | ₹17,36,511.00L | ₹15,54,193.00L | ₹14,91,908.00L | ₹14,29,548.00L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹23,37,924.00L | ₹17,95,996.00L | ₹17,30,198.00L | ₹17,68,487.00L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹83,87,974.00L | ₹72,48,595.00L | ₹67,12,594.00L | ₹59,31,547.00L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹24,90,548.00L | ₹19,61,463.00L | ₹18,37,371.00L | ₹21,42,812.00L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹4,23,443.00L | ₹2,00,393.00L | ₹2,97,005.00L | ₹6,32,596.00L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹39,289.00L | ₹35,826.00L | ₹30,362.00L | ₹55,991.00L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹33,78,146.00L | ₹26,31,764.00L | ₹19,32,865.00L | ₹15,41,486.00L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹2,28,344.00L | ₹1,42,042.00L | ₹1,38,931.00L | ₹1,52,112.00L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Free Cash Flow | ₹8,80,981.00L | ₹11,94,351.00L | ₹9,93,317.00L | ₹2,87,375.00L | ₹0.00L |
| Changes In Cash | -₹1,43,742.00L | ₹86,011.00L | ₹4,73,462.00L | -₹60,828.00L | ₹0.00L |
| End Cash Position | ₹9,77,051.00L | ₹10,26,877.00L | ₹9,28,565.00L | ₹4,62,373.00L | ₹0.00L |
| Financing Cash Flow | -₹2,51,255.00L | -₹7,90,582.00L | -₹6,71,016.00L | ₹2,37,607.00L | ₹0.00L |
| Investing Cash Flow | -₹11,34,405.00L | -₹5,30,616.00L | -₹69,020.00L | -₹7,94,368.00L | ₹0.00L |
| Operating Cash Flow | ₹12,41,918.00L | ₹14,07,209.00L | ₹12,13,498.00L | ₹4,95,933.00L | ₹0.00L |
| Capital Expenditure | -₹3,60,937.00L | -₹2,12,858.00L | -₹2,20,181.00L | -₹2,08,558.00L | ₹0.00L |
| Beginning Cash Position | ₹10,26,877.00L | ₹9,28,565.00L | ₹4,62,373.00L | ₹4,50,825.00L | ₹0.00L |
| Other Cash Adjustment Outside Changein Cash | ₹16,273.00L | -₹3.00L | ₹129.00L | ₹56,669.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹15,45,779.00L | ₹13,98,349.00L | ₹11,32,636.00L | ₹9,58,043.00L | ₹0.00L |
| EBITDA | ₹18,39,564.00L | ₹16,55,888.00L | ₹13,88,315.00L | ₹12,11,086.00L | ₹0.00L |
| Net Income | ₹11,47,942.00L | ₹10,92,904.00L | ₹9,57,638.00L | ₹8,47,358.00L | ₹3,27,273.00L |
| Gross Profit | ₹45,04,697.00L | ₹39,84,374.00L | ₹35,68,879.00L | ₹31,33,645.00L | ₹0.00L |
| Pretax Income | ₹15,11,888.00L | ₹13,75,213.00L | ₹11,08,789.00L | ₹9,40,843.00L | ₹0.00L |
| Tax Provision | ₹3,55,436.00L | ₹2,77,203.00L | ₹1,43,945.00L | ₹84,759.00L | ₹0.00L |
| Total Revenue | ₹58,22,011.00L | ₹52,04,125.00L | ₹47,75,845.00L | ₹43,27,887.00L | ₹38,65,449.00L |
| Cost Of Revenue | ₹13,17,314.00L | ₹12,19,751.00L | ₹12,06,966.00L | ₹11,94,242.00L | ₹0.00L |
| Total Expenses | ₹44,62,529.00L | ₹39,46,005.00L | ₹37,29,042.00L | ₹34,00,151.00L | ₹0.00L |
| Interest Income | ₹91,500.00L | ₹1,23,013.00L | ₹1,02,291.00L | ₹38,454.00L | ₹0.00L |
| Interest Expense | ₹33,891.00L | ₹23,136.00L | ₹23,847.00L | ₹17,200.00L | ₹0.00L |
| Operating Income | ₹13,59,482.00L | ₹12,58,120.00L | ₹10,46,803.00L | ₹9,27,736.00L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹18,84,840.00L | ₹16,72,549.00L | ₹14,29,380.00L | ₹12,29,231.00L | ₹0.00L |
| Normalized Income | ₹11,82,578.14L | ₹11,06,206.63L | ₹9,93,364.55L | ₹8,63,868.35L | ₹0.00L |
| Operating Expense | ₹31,45,215.00L | ₹27,26,254.00L | ₹25,22,076.00L | ₹22,05,909.00L | ₹0.00L |
| Operating Revenue | ₹58,22,011.00L | ₹52,04,125.00L | ₹47,75,845.00L | ₹43,27,887.00L | ₹0.00L |
| Net Interest Income | ₹57,609.00L | ₹99,877.00L | ₹78,444.00L | ₹21,254.00L | ₹0.00L |
| Total Unusual Items | -₹45,276.00L | -₹16,661.00L | -₹41,065.00L | -₹18,145.00L | ₹0.00L |
| Other Operating Expenses | ₹5,76,056.00L | ₹4,87,303.00L | ₹4,68,248.00L | ₹3,73,687.00L | ₹0.00L |
| Reconciled Depreciation | ₹2,93,785.00L | ₹2,57,539.00L | ₹2,55,679.00L | ₹2,53,043.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹13,17,314.00L | ₹12,19,751.00L | ₹12,06,966.00L | ₹11,94,242.00L | ₹0.00L |
| Rent Expense Supplemental | ₹9,940.00L | ₹7,774.00L | ₹7,343.00L | ₹5,887.00L | ₹0.00L |
| Tax Effect Of Unusual Items | -₹10,639.86L | -₹3,358.37L | -₹5,338.45L | -₹1,634.65L | ₹0.00L |
| Interest Income Non Operating | ₹91,500.00L | ₹1,23,013.00L | ₹1,02,291.00L | ₹38,454.00L | ₹0.00L |
| Selling And Marketing Expense | ₹7,74,824.00L | ₹6,57,686.00L | ₹5,78,026.00L | ₹5,22,624.00L | ₹0.00L |
| Interest Expense Non Operating | ₹33,891.00L | ₹23,136.00L | ₹23,847.00L | ₹17,200.00L | ₹0.00L |
| Net Income Common Stockholders | ₹11,47,942.00L | ₹10,92,904.00L | ₹9,57,638.00L | ₹8,47,358.00L | ₹0.00L |
| Net Income Continuous Operations | ₹11,50,865.00L | ₹10,96,475.00L | ₹9,61,003.00L | ₹8,51,294.00L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹11,47,942.00L | ₹10,92,904.00L | ₹9,57,638.00L | ₹8,47,358.00L | ₹0.00L |
| General And Administrative Expense | ₹3,72,917.00L | ₹3,72,359.00L | ₹3,43,714.00L | ₹2,81,846.00L | ₹0.00L |
| Selling General And Administration | ₹11,47,741.00L | ₹10,30,045.00L | ₹9,21,740.00L | ₹8,04,470.00L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹45,276.00L | -₹16,661.00L | -₹41,065.00L | -₹18,145.00L | ₹0.00L |
| Net Non Operating Interest Income Expense | ₹57,609.00L | ₹99,877.00L | ₹78,444.00L | ₹21,254.00L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹11,50,865.00L | ₹10,96,475.00L | ₹9,61,003.00L | ₹8,51,294.00L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹11,47,942.00L | ₹10,92,904.00L | ₹9,57,638.00L | ₹8,47,358.00L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹11,47,942.00L | ₹10,92,904.00L | ₹9,57,638.00L | ₹8,47,358.00L | ₹0.00L |
Company Performance (FY22–FY26)
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 01/04/2008 | Dilip Shantilal Shanghvi | 00005588 | Whole-time director | View other directorships |
| 25/05/2018 | Gautam Bhailal Doshi | 00004612 | Director | View other directorships |
| 21/05/2021 | Pawan Kumar Goenka | 00254502 | Director | View other directorships |
| 21/05/2021 | Rama Bijapurkar | 00001835 | Director | View other directorships |
| 31/01/2022 | Anoop Anjanikumar Deshpande | *****4865R | Company Secretary | |
| 01/06/2023 | Aalok Dilip Shanghvi | 01951829 | Whole-time director | View other directorships |
| 15/06/2023 | Rolf Karl Heinz Hoffmann | 10200311 | Director | View other directorships |
| 22/05/2025 | Vidhi Dilip Shanghvi | 06497350 | Whole-time director | View other directorships |
| 01/07/2025 | Jayashree Satagopan | *****4145B | CFO | |
| 01/09/2025 | Kirti Wardhaman Ganorkar | 10620142 | Managing Director | View other directorships |
Business Network
Directors 10
- Kirti Wardhaman GanorkarManaging Director
- Vidhi Dilip ShanghviWhole-time director
- Aalok Dilip ShanghviWhole-time director
- Dilip Shantilal ShanghviWhole-time director
- Rolf Karl Heinz HoffmannDirector
- Pawan Kumar GoenkaDirector
- Rama BijapurkarDirector
- Gautam Bhailal DoshiDirector
- Jayashree SatagopanCFO
- Anoop Anjanikumar DeshpandeCompany Secretary
Subsidiaries 7
- Sun Pharma (netherlands) B.v.Direct
- Sun Pharma Laboratories LimitedDirect
- Sun Pharma Distributors LimitedDirect
- Sun Pharmaceutical Industries (australia) Pty LtdUltimate
- Basics GmbhUltimate
- 晟华药业(海南)有限公司Ultimate
- Alkaloida Vegyészeti Gyár Zártkörűen Működő RészvénytársaságUltimate
Latest Documents
| Date | Title | Size |
|---|---|---|
| 23/09/2024 | Form MGT-7-23092024 | - |
| 03/09/2024 | Form AOC-4(XBRL)-03092024_signed | - |
| 30/03/2024 | Form Addendum to AOC-4 CSR-30032024_signed | - |
Charges
| SRN | Date | Amount | Holder |
|---|---|---|---|
| C72609175 | 18/02/2013 | ₹5,00,00,00,000.00 | Axis Trustee Services Limited |
| T62376165 | 31/03/2012 | ₹17,81,40,000.00 | Biotechnology Industry Research Assistance Council |
| G37394467 | 30/12/2005 | ₹72,85,00,000.00 | Citi Bank N.a. |
| G73789604 | 24/10/2003 | ₹3,00,00,00,000.00 | State Bank Of India |
| G38812848 | 09/04/2003 | ₹36,40,00,000.00 | Credit Lyonnais |
| G36283950 | 17/02/2003 | ₹30,17,00,000.00 | Deutche Bank |
| G73790206 | 03/07/2002 | ₹48,40,00,000.00 | Standard Chartered Bank |
| G35666973 | 24/10/2001 | ₹48,40,00,000.00 | The Hongkong And Shanghai Banking Corporation Ltd |
| G73653545 | 29/06/2001 | ₹72,85,00,000.00 | Abn Amro Bnak N V |
| G44510675 | 30/03/2001 | ₹2,12,25,00,000.00 | Punjab National Ban K |
| Y10188935 | 24/08/2000 | ₹5,00,000.00 | The Bank Of Nova Scona |
| Y10188908 | 07/07/2000 | ₹8,25,00,000.00 | The Bank Of Nova Scotia |
| Y10188889 | 22/05/2000 | ₹21,80,00,000.00 | Icici Bank Limited |
| Y10271134 | 20/08/1999 | ₹3,48,00,000.00 | Technology Development Board (department Of Science And T ) |
| C16158958 | 26/05/1999 | ₹75,00,000.00 | Lakshdeep Investment & Finance Pvt Ltd |
| Y10182237 | 26/05/1999 | ₹75,00,000.00 | Nvfc Finance Private Ltd |
| Y10181712 | 29/04/1999 | ₹1,50,00,000.00 | Risk Capital And Technology Finance Corporation Ltd |
| C16159626 | 08/12/1998 | ₹13,45,00,000.00 | Lakshdeep Investment & Finance Pvt Ltd |
| Y10181683 | 17/11/1998 | ₹3,25,00,000.00 | Industrial Development Bank Of India |
| Y10191569 | 23/09/1998 | ₹25,00,00,000.00 | Icici Limited |
| Y10186233 | 16/06/1998 | ₹67,20,00,000.00 | Bank Of Baroda |
| Y10186173 | 14/09/1997 | ₹15,82,00,000.00 | Bank Of Baroda |
| Y10188296 | 15/05/1997 | ₹40,00,00,000.00 | The Industrial Credit & Investment Corporation Of India Ltd. |
| G51773588 | 07/05/1997 | ₹6,00,00,000.00 | Icici Banking Corporation Ltd. |
| G73788580 | 21/09/1996 | ₹7,50,00,000.00 | Anz Grindlays Bank Ltd. |
| Y10181537 | 13/09/1996 | ₹9,20,00,000.00 | Industrial Development Bank Of India |
| Y10187956 | 13/10/1995 | ₹3,00,00,000.00 | Anz Grindlays Bank |
| G74082454 | 03/07/1995 | ₹1,26,00,00,000.00 | Icici Bank Limited |
| G74064015 | 03/07/1995 | ₹25,25,00,000.00 | Bank Of Baroda |
| G74064452 | 03/07/1995 | ₹25,25,00,000.00 | Bank Opf Baroda |
| G74063793 | 28/06/1995 | ₹17,80,00,000.00 | Bank Of Baroda |
| G74062829 | 28/01/1995 | ₹17,80,00,000.00 | Bank Of Baroda |
| G51775047 | 25/10/1993 | ₹2,00,00,000.00 | The S.c.i.c.i. Ltd. |
| Y10191137 | 11/10/1993 | ₹1,36,00,000.00 | Gujarat Industrial Investment Corporation Ltd. |
| G51775922 | 05/10/1993 | ₹4,70,00,000.00 | The Industrial Credit & Investment Corporation Of India Ltd. |
| Y10191136 | 05/10/1993 | ₹4,70,00,000.00 | The Industrial Credit & Investemnt Corporation Of India Ltd. |
| G74058710 | 06/04/1993 | ₹8,78,31,000.00 | Bank Of Baroda |
| Y10270327 | 24/04/1991 | ₹1,50,00,000.00 | Deutshe Bank A G |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Direct/Ultimate Children
| Type | Legal Name | LEI code |
|---|---|---|
| Direct | Sun Pharma (netherlands) B.v. | 254900PV2P7V6VF3M543 |
| Direct | Sun Pharma Laboratories Limited | 335800OSX5QMN9K4HA44 |
| Direct | Sun Pharma Distributors Limited | 98450091KB8064954651 |
| Ultimate | Sun Pharmaceutical Industries (australia) Pty Ltd | 254900KIYTXK9FU0L170 |
| Ultimate | Basics Gmbh | 391200GUG3BLLRHJS167 |
| Ultimate | 晟华药业(海南)有限公司 | 836800JCBGW25DPN6Z77 |
| Ultimate | Alkaloida Vegyészeti Gyár Zártkörűen Működő Részvénytársaság | 984500110OAUC30ZY157 |
Address
Frequently Asked Questions
The current board member of Sun Pharmaceutical Industries Limited are:
- Pawan Kumar Goenka
- Anoop Anjanikumar Deshpande
- Dilip Shantilal Shanghvi
- Gautam Bhailal Doshi
- Rama Bijapurkar
- Jayashree Satagopan
- Kirti Wardhaman Ganorkar
- Vidhi Dilip Shanghvi
- Aalok Dilip Shanghvi
- Rolf Karl Heinz Hoffmann